Christopher Blanchard

Christopher Blanchard

Auto-generated profile, based on publicly available information

Christopher Blanchard

Dalhousie University

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2015 in JMIR Cancer
Verified
Journal Article
Open access
CFCynthia Forbes
Cynthia Forbes
CBChris M Blanchard
Chris M Blanchard
WMW Kerry Mummery
W Kerry Mummery
OCOralee Courneya
Oralee Courneya
Patient-Centered Innovations, Education and Technology for Cancer Care and Cancer Research

5 October 2015 in BMC Public Health
Verified
Journal Article
Open access
PDF file
AQAlison Quinlan
Alison Quinlan
RRRyan E Rhodes
Ryan E Rhodes
CBChris M. Blanchard
Chris M. Blanchard
PNPatti-Jean Naylor
Patti-Jean Naylor
DWDarren Warburton
Darren Warburton
Physical activity is associated with the reduction of several chronic conditions in adults. Additionally, physical activity is extremely important for children for their development and cognitive functioning and also to create a physically active lifestyle that continues into adulthood. Despite the known benefits of physical activity, only one in five adults are achieving the public health recommendations of 150 minutes of moderate-to-vigorous physical activity per week and only 13 % of boys and 6 % of girls between the ages of 5 and 17 years are meeting the guidelines of 60 minutes per day. This study aims to evaluate whether a planning condition improves adherence to regular physical activity compared to an education-only control condition among families. Families are eligible if there is at least one child between the ages of 6 and 12 years who is not meeting the Canadian Physical Activity Guidelines. A six-month longitudinal randomized controlled trial will be used to compare the two conditions. Materials will be delivered at baseline with ‘booster’ sessions at six weeks and three months. Participants will be assessed at baseline and at six months with a fitness test, as well as questionnaires and accelerometery at baseline, six weeks, three months and six months. A total of 137 families have been recruited thus far from Greater Victoria. This study is ongoing and recruitment will continue until December 2015 with the target goal of reaching 160 families. This protocol describes the implementation of a randomized controlled trial that utilizes planning strategies to try and increase physical activity among families. Research findings could be useful in public health in providing effective strategies to families to help decrease sedentary lifestyles. Additionally, findings may help to inform future interventions aimed at increasing physical activity among families. This trial was registered on June 5, 2012 with the Clinical Trials Registry maintained by the National Library of Medicine at the National Institutes of Health. The registration ID is NCT01882192 .

1 January 2014 in Cancer Nursing
Verified
Journal Article
Closed access
ASAmy E. Speed-Andrews
Amy E. Speed-Andrews
EMErin L. McGowan
Erin L. McGowan
RRRyan E Rhodes
Ryan E Rhodes
CBChris M. Blanchard
Chris M. Blanchard
S.Nicole Culos-ReedS.Nicole Culos-Reed
S.Nicole Culos-Reed
OCOralee Courneya
Oralee Courneya
Background: Physical activity (PA) has been associated with lower risk of disease recurrence and longer survival in colorectal cancer (CRC) survivors; however, less than one-third of CRC survivors are meeting PA guidelines. Interventions to promote PA in CRC survivors need to understand the most critical beliefs that influence PA behavior. Objective: The objective of this study was to examine the strength of associations between the most common PA beliefs of CRC survivors and motivational constructs from the Theory of Planned Behavior (TPB) as well as PA behavior. Intervention/Methods: Colorectal cancer survivors (n = 600) residing in Alberta, Canada, completed self-report questionnaires assessing medical and demographic variables, PA beliefs, constructs from the TPB, and PA behavior. Results: Colorectal cancer survivors identified improved fitness (69.5%), family members (67.3%), and medical/health problems (8.8%) as the most prevalent behavioral, normative, and control beliefs, respectively. All PA beliefs were significantly correlated with all TPB constructs and PA. Conclusions: Physical activity interventions for CRC survivors should target many salient beliefs including behavioral, normative, and control beliefs. Implications for Practice: Insights into the salient beliefs for PA in CRC survivors can guide nurses in developing successful strategies to promote PA in this population and likely improve quality of life and possibly disease outcomes.

26 May 2012 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
EMErin L. McGowan
Erin L. McGowan
ASAmy E. Speed-Andrews
Amy E. Speed-Andrews
RRRyan E Rhodes
Ryan E Rhodes
CBChris M. Blanchard
Chris M. Blanchard
S.Nicole Culos-ReedS.Nicole Culos-Reed
S.Nicole Culos-Reed
OCOralee Courneya
Oralee Courneya

19 September 2016 in Cross-Cultural Research
Verified
Journal Article
Closed access
PDF file
SBShea M. Balish
Shea M. Balish
RDRobert O. Deaner
Robert O. Deaner
Daniel RainhamDaniel Rainham
Daniel Rainham
CBChris Blanchard
Chris Blanchard
The spectator lek hypothesis argues that sex differences in preferences for sport largely stem from evolved predispositions and thus should be universal or near universal, whereas socioconstructivist hypotheses argue that such sex differences are entirely socially constructed and thus should vary as a function of a society’s gender inequality. To test these competing hypotheses, cross-national nested data were acquired from the International Social Survey Program (ss = 49,729, ncountries = 34). Hierarchical linear modeling was used to examine whether sex differences in sport are universal or near universal when controlling for countries’ gender inequality. Findings indicate that even when controlling for gender inequality, sex differences remain in reporting sport as one’s most common activity, in watching sport, and in attending sport events and for agreeing with the statement that one plays sport to compete against others. Although this study was limited by the homogeneity of the sampled countries and the use of self-report measures, these findings nonetheless support the spectator lek hypothesis. Future research should examine case studies (e.g., matrilineal societies) that can specifically test the assumptions of the spectator lek hypothesis.

4 May 2022 in JMIR Research Protocols
Verified
Journal Article
Open access
Melanie KeatsMelanie Keats
Melanie Keats
Scott A. GrandyScott A. Grandy
Scott A. Grandy
CBChristopher Blanchard
Christopher Blanchard
JFJonathon Richard Fowles
Jonathon Richard Fowles
HNHeather F. Neyedli
Heather F. Neyedli
MMMary V MacNeil
Mary V MacNeil
Background: Glioblastoma is the most common primary brain malignancy in adults, accounting for approximately 48% of all brain tumors. Standard treatment includes radiation and temozolomide chemotherapy. Glioblastomas are highly vascular and can cause vasogenic brain edema and mass effect, which can worsen the neurologic symptoms associated with the disease. The steroid dexamethasone (DEX) is the treatment of choice to reduce vasogenic edema and intracranial pressure associated with glioblastoma. However high-dose DEX or long-term use can result in muscle myopathy in 10%-60% of glioblastoma patients, significantly reducing functional fitness and quality of life (QOL). There is a wealth of evidence to support the use of exercise as an adjuvant therapy to improve functional ability as well as help manage treatment-related symptoms. Specifically, resistance training has been shown to increase muscle mass, strength, and functional fitness in aging adults and several cancer populations. Although studies are limited, research has shown that exercise is safe and feasible in glioblastoma populations. However, it is not clear whether resistance training can be successfully used in glioblastoma to prevent or mitigate steroid-induced muscle myopathy and associated loss of function. Objective: The primary purpose of this study is to establish whether an individualized circuit-based program will reduce steroid-induced muscle myopathy, as indicated by maintained or improved functional fitness for patients on active treatment and receiving steroids. Methods: This is a 2-armed, randomized controlled trial with repeated measures. We will recruit 38 adult (≥18 years) patients diagnosed with either primary or secondary glioblastoma who are scheduled to receive standard radiation and concurrent and adjuvant temozolomide chemotherapy postsurgical debulking and received any dose of DEX through the neurooncology clinic and the Nova Scotia Health Cancer Center. Patients will be randomly allocated to a standard of care waitlist control group or standard of care + circuit-based resistance training exercise group. The exercise group will receive a 12-week individualized, group and home-based exercise program. The control group will be advised to maintain an active lifestyle. The primary outcome, muscle myopathy (functional fitness), will be assessed using the Short Physical Performance Battery and hand grip strength. Secondary outcome measures will include body composition, cardiorespiratory fitness, physical activity, QOL, fatigue, and cognitive function. All measures will be assessed pre- and postintervention. Participant accrual, exercise adherence, and safety will be assessed throughout the study. Results: This study has been funded by the Canadian Cancer Society Atlantic Cancer Research Grant and the J.D. Irving Limited–Excellence in Cancer Research Fund (grant number 707182). The protocol was approved by the Nova Scotia Health and Acadia University’s Research Ethics Boards. Enrollment is anticipated to begin in March 2022. Conclusions: This study will inform how individualized circuit-based resistance training may improve functional independence and overall QOL of glioblastoma patients. Trial Registration: ClinicalTrails.gov NCT05116137; https://www.clinicaltrials.gov/ct2/show/NCT05116137 International Registered Report Identifier (IRRID): DERR1-10.2196/37709